| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $608.2M | +2143.3% |
| Cost of Revenue | $1.65B | +962.7% |
| R&D Expense | $821.5M | +9.5% |
| SG&A Expense | $734.6M | +12.6% |
| Operating Income | -$2.59B | -69.5% |
| Interest Expense | $30.6M | +2126.8% |
| Pre-tax Income | -$1.30B | +49.4% |
| Income Tax | $379K | +673.5% |
| Net Income | -$1.30B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.74B | -72.3% |
| Short-term Investments | $2.18B | — |
| Accounts Receivable | $19.5M | +520.8% |
| Inventory | $834.4M | +555.7% |
| Current Assets | $4.91B | -24.5% |
| Total Assets | $7.88B | -0.0% |
| Current Liabilities | $937.6M | +136.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.23B | -110.4% |
| Capital Expenditures | $1.07B | +155.2% |
| Investing Cash Flow | -$3.68B | -775.1% |
| Financing Cash Flow | $1.35B | -81.1% |
| Free Cash Flow | -$3.30B | -123.1% |
| +49.4% |
| EPS (Basic) | -$0.78 | +87.8% |
| EPS (Diluted) | -$1.51 | +76.4% |
| Long-term Debt |
| $1.99B |
| +0.3% |
| Total Liabilities | $3.53B | -11.1% |
| Stockholders' Equity | $4.35B | +11.3% |